Protein Variants | Comment | Organism |
---|---|---|
S315G | site-directed mutagenesis, modelling and docking and interaction analysis with isoniazid, comparison to wild-type | Mycobacterium tuberculosis |
S315I | site-directed mutagenesis, modelling and docking and interaction analysis with isoniazid, comparison to wild-type | Mycobacterium tuberculosis |
S315N | site-directed mutagenesis, modelling and docking and interaction analysis with isoniazid, comparison to wild-type | Mycobacterium tuberculosis |
S315R | site-directed mutagenesis, modelling and docking and interaction analysis with isoniazid, comparison to wild-type | Mycobacterium tuberculosis |
S315T | site-directed mutagenesis, modelling and docking and interaction analysis with isoniazid, comparison to wild-type | Mycobacterium tuberculosis |
Inhibitors | Comment | Organism | Structure |
---|---|---|---|
isoniazid | mutation at position 315 in the katG gene, encoding the catalase-peroxidase (KatG) enzyme, is the major cause of isoniazid (INH) resistance in Mycobacterium tuberculosis. INH resistance is regarded as a major impediment to the tuberculosis (TB) control programme and contributes to the emergence of multidrug-resistant strains. Analysis of the molecular mechanisms of INH resistance, overview. The five KatG mutations, S315T, S315I, S315R, S315N and S315G, affect enzyme activity in different ways, which can be attributed to conformational changes in mutant KatG that result in altered binding affinity to INH and eventually to INH resistance, docking study. Analysis of molecular dynamics (MD) experiments suggest that fluctuations and deviations are higher at the INH binding residues for the mutants than for the wild-type. Reduction in the hydrogen bond network after MD in all KatG enzymes implies an increase in the flexibility and stability of protein structures. Since KatG is a conjugated protein, docking is first done with heme, and then it is further docked with INH | Mycobacterium tuberculosis |
Metals/Ions | Comment | Organism | Structure |
---|---|---|---|
Fe2+ | in the heme group | Mycobacterium tuberculosis |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Mycobacterium tuberculosis | P9WIE5 | - |
- |
Mycobacterium tuberculosis ATCC 25618 | P9WIE5 | - |
- |
Mycobacterium tuberculosis H37Rv | P9WIE5 | - |
- |
Synonyms | Comment | Organism |
---|---|---|
KatG | - |
Mycobacterium tuberculosis |
Rv1908c | - |
Mycobacterium tuberculosis |
Cofactor | Comment | Organism | Structure |
---|---|---|---|
heme | docking study with wild-type and mutant enzymes, molecular dynamics, overview | Mycobacterium tuberculosis |
General Information | Comment | Organism |
---|---|---|
malfunction | mutation at position 315 in the katG gene, encoding the catalase-peroxidase (KatG) enzyme, is the major cause of isoniazid (INH) resistance in Mycobacterium tuberculosis. INH resistance is regarded as a major impediment to the tuberculosis (TB) control programme and contributes to the emergence of multidrug-resistant strains. Analysis of the molecular mechanisms of INH resistance, overview. The five KatG mutations, S315T, S315I, S315R, S315N and S315G , affect enzyme activity in different ways, which can be attributed to conformational changes in mutant KatG that result in altered binding affinity to INH and eventually to INH resistance, docking study. Analysis of molecular dynamics (MD) experiments suggest that fluctuations and deviations are higher at the INH binding residues for the mutants than for the wild-type. Reduction in the hydrogen bond network after MD in all KatG enzymes implies an increase in the flexibility and stability of protein structures. Since KatG is a conjugated protein, docking is first done with heme, and then it is further docked with INH | Mycobacterium tuberculosis |